vs
Nomad Foods Ltd（NOMD）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Nomad Foods Ltd的1.7倍（$1.4B vs $834.9M），瑞思迈同比增速更快（11.0% vs -2.6%），瑞思迈自由现金流更多（$311.2M vs $272.4M）
游牧食品（Nomad Foods）是欧洲最大的冷冻食品企业，总部位于英国，业务覆盖22个欧洲市场，从事冷冻食品的生产、销售与配送工作。旗下拥有Birds Eye、Ledo、Iglo、Findus、Frikom等知名品牌，核心产品包括鱼条、奶油菠菜、豌豆、鸡肉类冷冻食品，在纽交所上市，股票代码为NOMD。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
NOMD vs RMD — 直观对比
营收规模更大
RMD
是对方的1.7倍
$834.9M
营收增速更快
RMD
高出13.5%
-2.6%
自由现金流更多
RMD
多$38.8M
$272.4M
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $834.9M | $1.4B |
| 净利润 | — | $392.6M |
| 毛利率 | 25.6% | 61.8% |
| 营业利润率 | 9.1% | 34.6% |
| 净利率 | — | 27.6% |
| 营收同比 | -2.6% | 11.0% |
| 净利润同比 | — | 13.9% |
| 每股收益（稀释后） | — | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NOMDRMD
| Q4 25 | $834.9M | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $856.9M | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
净利润NOMDRMD
| Q4 25 | — | $392.6M | ||
| Q3 25 | — | $348.5M | ||
| Q2 25 | — | $379.7M | ||
| Q1 25 | — | $365.0M | ||
| Q4 24 | $55.5M | $344.6M | ||
| Q3 24 | — | $311.4M | ||
| Q2 24 | — | $292.2M | ||
| Q1 24 | — | $300.5M |
毛利率NOMDRMD
| Q4 25 | 25.6% | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | 28.5% | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率NOMDRMD
| Q4 25 | 9.1% | 34.6% | ||
| Q3 25 | — | 33.4% | ||
| Q2 25 | — | 33.7% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | 11.5% | 32.5% | ||
| Q3 24 | — | 31.6% | ||
| Q2 24 | — | 31.2% | ||
| Q1 24 | — | 31.3% |
净利率NOMDRMD
| Q4 25 | — | 27.6% | ||
| Q3 25 | — | 26.1% | ||
| Q2 25 | — | 28.2% | ||
| Q1 25 | — | 28.3% | ||
| Q4 24 | 6.5% | 26.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 23.9% | ||
| Q1 24 | — | 25.1% |
每股收益（稀释后）NOMDRMD
| Q4 25 | — | $2.68 | ||
| Q3 25 | — | $2.37 | ||
| Q2 25 | — | $2.58 | ||
| Q1 25 | — | $2.48 | ||
| Q4 24 | — | $2.34 | ||
| Q3 24 | — | $2.11 | ||
| Q2 24 | — | $1.97 | ||
| Q1 24 | — | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | $2.5B | $403.9M |
| 股东权益账面价值 | $2.7B | $6.3B |
| 总资产 | $6.8B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.92× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资NOMDRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M | ||
| Q2 24 | — | $238.4M | ||
| Q1 24 | — | $237.9M |
总债务NOMDRMD
| Q4 25 | $2.5B | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | $2.4B | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益NOMDRMD
| Q4 25 | $2.7B | $6.3B | ||
| Q3 25 | — | $6.1B | ||
| Q2 25 | — | $6.0B | ||
| Q1 25 | — | $5.5B | ||
| Q4 24 | $2.9B | $5.3B | ||
| Q3 24 | — | $5.2B | ||
| Q2 24 | — | $4.9B | ||
| Q1 24 | — | $4.6B |
总资产NOMDRMD
| Q4 25 | $6.8B | $8.5B | ||
| Q3 25 | — | $8.3B | ||
| Q2 25 | — | $8.2B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $6.9B | $7.1B | ||
| Q3 24 | — | $7.2B | ||
| Q2 24 | — | $6.9B | ||
| Q1 24 | — | $6.8B |
负债/权益比NOMDRMD
| Q4 25 | 0.92× | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | 0.82× | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $357.2M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $272.4M | $311.2M |
| 自由现金流率自由现金流/营收 | 32.6% | 21.9% |
| 资本支出强度资本支出/营收 | 10.2% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | $1.3B | $1.8B |
8季度趋势，按日历期对齐
经营现金流NOMDRMD
| Q4 25 | $357.2M | $339.7M | ||
| Q3 25 | — | $457.3M | ||
| Q2 25 | — | $538.8M | ||
| Q1 25 | — | $578.7M | ||
| Q4 24 | $470.2M | $308.6M | ||
| Q3 24 | — | $325.5M | ||
| Q2 24 | — | $440.1M | ||
| Q1 24 | — | $402.0M |
自由现金流NOMDRMD
| Q4 25 | $272.4M | $311.2M | ||
| Q3 25 | — | $414.4M | ||
| Q2 25 | — | $508.2M | ||
| Q1 25 | — | $557.9M | ||
| Q4 24 | $383.5M | $288.0M | ||
| Q3 24 | — | $307.7M | ||
| Q2 24 | — | $415.2M | ||
| Q1 24 | — | $380.8M |
自由现金流率NOMDRMD
| Q4 25 | 32.6% | 21.9% | ||
| Q3 25 | — | 31.0% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | 44.8% | 22.5% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 33.9% | ||
| Q1 24 | — | 31.8% |
资本支出强度NOMDRMD
| Q4 25 | 10.2% | 2.0% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | 10.1% | 1.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 1.8% |
现金转化率NOMDRMD
| Q4 25 | — | 0.87× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | 8.47× | 0.90× | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | — | 1.51× | ||
| Q1 24 | — | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NOMD
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
